BioAsia 2026 begins in Hyderabad with focus on AI-driven life sciences
BioAsia 2026 began in Hyderabad with global stakeholders converging to discuss AI-driven life sciences, as Chief Minister A Revanth Reddy highlighted Telangana’s policy initiatives, investments and ambitions to emerge as a top global life sciences hub
Published Date - 18 February 2026, 12:11 AM
Hyderabad: The 23rd edition of BioAsia 2026 commenced on Tuesday bringing together stakeholders from across the globe, including those from biotechnology, pharmaceuticals, Medtech, digital health, research, investment, and policy sectors. The theme this year is ‘TechBio Unleashed: AI, Automation, and the Biology Revolution’.
At the inaugural ceremony, Chief Minister A Revanth Reddy spoke about the recent launch of Telangana Next-Gen Life Sciences Policy at Davos, the expansion of Genome Valley, launch of 1Bio or world-class research and innovation, the acceleration of Green Pharma City, and opening of various global capability centres in Hyderabad.
“In the last two years, Telangana received investments worth over Rs.73,000 crore in the life sciences sector,” he said, adding that Hyderabad had emerged as the preferred destination to set up GCCs, build innovation engines, design molecules and drugs, AI platforms and drive digital manufacturing.
The Chief Minister presented Prof. Bruce Levine from the University of Pennsylvania, with the Genome Valley Excellence Award.
IT and Industries Minister Duddilla Sridhar Babu said that the State government was aiming to attract investments worth US $ 25 billion in the life sciences sector by 2030 and generate five lakh new jobs. The Telangana Next-Gen Life Sciences Policy (2026–2030) was formulated to position the State among the top three life sciences clusters globally by the end of this decade. A dedicated policy has also been introduced to develop Hyderabad as a global medical tourism hub, he added.
During the inaugural ceremony, investment announcements were made by Opella Healthcare (France), Vaksindo Animal Health Private Limited (division of JAPFA, Indonesia), Tredence Inc (USA), and Rx Propellant (RxP). The convention will conclude on Wednesday.